Jiangxi University of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 2
Founded: Nanchang China (1959)

Organization Overview

First Clinical Trial
2016
NCT03025152
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated hospital of jiangxi university of traditional Chinese medicine | Jiangxi University of Traditional Chinese Medicine | The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine | The Second Affiliated Hospital of Jiangxi University of TCM

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blind Loop Syndrome (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Psoriasis (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 7